Watermelon Supplementation and Arterial Stiffness
Primary Purpose
Hypertension
Status
Completed
Phase
Phase 1
Locations
United States
Study Type
Interventional
Intervention
Watermelon Extract
Sponsored by

About this trial
This is an interventional treatment trial for Hypertension focused on measuring Arterial Stiffness, Wave Reflection, Watermelon Supplementation, Aortic Blood Pressure, Obesity
Eligibility Criteria
Inclusion Criteria:
- Thirty men and women 45-70 years of age
- BP between 120-159/80-99 mmHg
- Waist circumference >102 cm in men and > 80 cm in women
Exclusion Criteria:
- BP >160/100 mmHg
- Asthma
- Glaucoma
- Herpes simplex
- Uncontrolled diabetes
- Neurological disease
- Cardiovascular disease
- Inflammatory disease
- Kidney disease
- Hormone replacement therapy (HRT)
- Amino acid/vitamin supplementation\
- Corticosteroids or non-steroidal anti-inflammatory drugs
- Any drug known to affect BP or heart rate
- Glycemic control drugs
- Lipids reducing drugs
- Participants should not consume > 12 alcoholic drink/week
- Smokers
- Regular Exercisers (= 1.5 hour/week).
Sites / Locations
- Cardiovascular Physiology Laboratory
Arms of the Study
Arm 1
Arm 2
Arm Type
Placebo Comparator
Experimental
Arm Label
Maltodextrin
Watermelon
Arm Description
6g/day of placebo (maltodextrin)
(6g per day)containing L-citrulline/L-arginine (4/2 g)
Outcomes
Primary Outcome Measures
Blood Pressure
By measuring brachial and central (aortic and carotid) BP at rest and during physiological stress (head-up tilt test and cold pressor test)
Secondary Outcome Measures
Arterial Stiffness
Using pulse wave velocity of the aorta and legs.
Endothelial function
By measuring flow-mediated dilation using vascular ultrasound and circulating levels of vasodilators, vasoconstrictors, and markers of vascular inflammation (adiponectin, leptin, endothelin-1, angiotensin II, prostaglandin F2α, sVCAM-1, sICAM-1, and 8-isoprostane).
Autonomic control of BP
By measuring BP variability and BRS at rest and during physiological stress
Autonomic control of heart rate
By measuring heart rate variability at rest and during physiological stress
Full Information
NCT ID
NCT01185041
First Posted
August 17, 2010
Last Updated
March 17, 2012
Sponsor
Florida State University
1. Study Identification
Unique Protocol Identification Number
NCT01185041
Brief Title
Watermelon Supplementation and Arterial Stiffness
Official Title
Effects of Oral L-citrulline/L-arginine in Watermelon on Central Blood Pressure and Arterial Stiffness in Individuals With Obesity-related High Blood Pressure
Study Type
Interventional
2. Study Status
Record Verification Date
March 2012
Overall Recruitment Status
Completed
Study Start Date
August 2010 (undefined)
Primary Completion Date
August 2011 (Actual)
Study Completion Date
August 2011 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Florida State University
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Increased abdominal obesity (waist circumference) and systolic blood pressure (BP) are main risk factors for the metabolic syndrome. Approximately 60% of adults in the United States are prehypertensive or hypertensive. Hypertension has been associated with abnormal endothelial and autonomic function, the two main mechanisms of BP regulation. Endothelial dysfunction, as a result of reduced NO (a vasodilator), and increased sympathetic nervous system activity contribute to arterial stiffness by enhancing the vasomotor tone. Because BP variations are sensed by baroreceptors in the wall of large arteries, increased stiffness of arteries may attenuate the control of BP by the autonomic nervous system leading to hypertension. High production of proinflammatory cytokines and low adiponectin (vascular protective molecule), are considered the underlying mechanisms leading to endothelial dysfunction and arterial stiffness. The recommended intervention for controlling BP in overweight/obese individuals with pre- and stage 1- hypertension is lifestyle modifications and not drug therapy. Among the dietary regimens that are reported to reduce BP is L-arginine, the substrate for endothelial NO production. Recently, oral L-citrulline has been shown to be more effective than L-arginine in improving circulating NO levels because is not affected by enzymatic degradation. Watermelon, the leading US melon crop, is one of the few natural foods rich in L-citrulline which is efficiently transformed to arginine in humans. The investigators long-term goal is to provide feasible and effective dietary ways to reduce cardiovascular risk factors in individuals with high abdominal fat and BP. The overall objective of this study is to bring forth evidence that watermelon supplementation will reduce BP and cardiovascular risk factors such as arterial stiffness, autonomic dysfunction and endothelial dysfunction. The investigators postulate that watermelon supplementation will reduce BP and arterial stiffness by enhancing endothelial function and reducing vascular inflammation. The findings of this study will provide a foundation for disseminating feasible, safe approaches for preventing and combating obesity-related hypertension at its early stage which does not require drug therapy.
Detailed Description
The purpose of the study is to examine the effect of 12 weeks of L-citrulline/L-arginine in the form of watermelon supplementation on arterial function and autonomic neural control of the heart rate and blood pressure in older overweight/obese men and women with pre- and stage 1- hypertension. The specific aims of the study are:
To investigate the extent to which daily consumption of watermelon supplementation containing L-citrulline/L-arginine (4/2 g) will reduce BP and arterial stiffness. This aim will examine the working hypothesis that watermelon supplementation will reduce BP and improve arterial function. This aim will be tested by measuring brachial and central (aortic and carotid) BP at rest and during physiological stress (head-up tilt test and cold pressor test), and by evaluating arterial stiffness using pulse wave velocity of the aorta and legs as primary variables.
To determine the effect of watermelon supplementation on endothelial function. There is evidence that watermelon improves endothelial function in rats. Hence, we postulate that watermelon in part exerts its vascular protective effects by modulating indices of endothelial function. This aim will be tested by measuring flow-mediated dilation using vascular ultrasound and circulating levels of vasodilators, vasoconstrictors, and markers of vascular inflammation (adiponectin, leptin, endothelin-1, angiotensin II, prostaglandin F2α, sVCAM-1, sICAM-1, and 8-isoprostane).
To determine whether watermelon supplementation will improve the autonomic control of BP and heart rate in individuals with high abdominal obesity and BP. There is evidence that food high in L-arginine improves baroreflex sensitivity (BRS) in individuals with pre-hypertension. This aim will examine the working hypothesis that watermelon will improve cardiovascular autonomic control of BP by measuring heart rate variability, BP variability and BRS at rest and during physiological stress as secondary variables.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hypertension
Keywords
Arterial Stiffness, Wave Reflection, Watermelon Supplementation, Aortic Blood Pressure, Obesity
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 1, Phase 2
Interventional Study Model
Crossover Assignment
Masking
ParticipantOutcomes Assessor
Allocation
Randomized
Enrollment
20 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Maltodextrin
Arm Type
Placebo Comparator
Arm Description
6g/day of placebo (maltodextrin)
Arm Title
Watermelon
Arm Type
Experimental
Arm Description
(6g per day)containing L-citrulline/L-arginine (4/2 g)
Intervention Type
Dietary Supplement
Intervention Name(s)
Watermelon Extract
Other Intervention Name(s)
Watermelon extract from Milne fruit Products Inc
Intervention Description
6 weeks of watermelon extract taken in two doses of 3g each per day (6g per day)containing L-citrulline/L-arginine (4/2 g)
Primary Outcome Measure Information:
Title
Blood Pressure
Description
By measuring brachial and central (aortic and carotid) BP at rest and during physiological stress (head-up tilt test and cold pressor test)
Time Frame
12 weeks
Secondary Outcome Measure Information:
Title
Arterial Stiffness
Description
Using pulse wave velocity of the aorta and legs.
Time Frame
12 weeks
Title
Endothelial function
Description
By measuring flow-mediated dilation using vascular ultrasound and circulating levels of vasodilators, vasoconstrictors, and markers of vascular inflammation (adiponectin, leptin, endothelin-1, angiotensin II, prostaglandin F2α, sVCAM-1, sICAM-1, and 8-isoprostane).
Time Frame
12 weeks
Title
Autonomic control of BP
Description
By measuring BP variability and BRS at rest and during physiological stress
Time Frame
12 weeks
Title
Autonomic control of heart rate
Description
By measuring heart rate variability at rest and during physiological stress
Time Frame
12 weeks
10. Eligibility
Sex
All
Minimum Age & Unit of Time
45 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Thirty men and women 45-70 years of age
BP between 120-159/80-99 mmHg
Waist circumference >102 cm in men and > 80 cm in women
Exclusion Criteria:
BP >160/100 mmHg
Asthma
Glaucoma
Herpes simplex
Uncontrolled diabetes
Neurological disease
Cardiovascular disease
Inflammatory disease
Kidney disease
Hormone replacement therapy (HRT)
Amino acid/vitamin supplementation\
Corticosteroids or non-steroidal anti-inflammatory drugs
Any drug known to affect BP or heart rate
Glycemic control drugs
Lipids reducing drugs
Participants should not consume > 12 alcoholic drink/week
Smokers
Regular Exercisers (= 1.5 hour/week).
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Arturo Figueroa, MD, PhD
Organizational Affiliation
The Florida State University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Cardiovascular Physiology Laboratory
City
Tallahassee
State/Province
Florida
ZIP/Postal Code
32306
Country
United States
12. IPD Sharing Statement
Citations:
PubMed Identifier
24572702
Citation
Figueroa A, Wong A, Kalfon R. Effects of watermelon supplementation on aortic hemodynamic responses to the cold pressor test in obese hypertensive adults. Am J Hypertens. 2014 Jul;27(7):899-906. doi: 10.1093/ajh/hpt295. Epub 2014 Feb 26.
Results Reference
derived
Learn more about this trial
Watermelon Supplementation and Arterial Stiffness
We'll reach out to this number within 24 hrs